title: Denosumab chemotherapy for recurrent giant-cell tumor of bone: a case report of neoadjuvant use enabling complete surgical resection.
abstract: Giant-cell tumor of the bone (GCTB) is a rare neoplasm that affects young adults. The tumor is generally benign but sometimes can be locally aggressive. There are no standardized approaches to the treatment of GCTB. Recently, the RANKL inhibitor denosumab has shown activity in this tumor type. We present the case of a young female who presented with locally advanced disease and was successfully managed with the neoadjuvant use of denosumab allowing for surgical resection of the tumor that was previously deemed unresectable. Following surgery, the patient is being managed with continued use of denosumab as 'maintenance,' and she continues to be free of disease. Our case highlights a novel approach for the management of locally advanced and aggressive giant cell tumor of the bone.
authors: Department of Medicine, Southern Arizona Veterans Affairs Health Care System, 3601 S 6th Avenue, Tucson, AZ 85723, USA.
authors: Amit
authors: A
authors: Agarwal
authors: Brandon T
authors: BT
authors: Larsen
authors: Lawrence D
authors: LD
authors: Buadu
authors: Jack
authors: J
authors: Dunn
authors: Russell
authors: R
authors: Crawford
authors: Jonathan
authors: J
authors: Daniel
authors: Maria C
authors: MC
authors: Bishop
references: Clin Cancer Res. 2012 Aug 15;18(16):4415-24
references: 22711702
references: Curr Opin Oncol. 2009 Jul;21(4):338-44
references: 19444102
references: Compr Ther. 1993;19(2):64-8
references: 8370248
references: J Bone Joint Surg Am. 1987 Jan;69(1):106-14
references: 3805057
references: Am J Clin Oncol. 2006 Feb;29(1):96-9
references: 16462511
references: Semin Diagn Pathol. 2011 Feb;28(1):73-85
references: 21675379
references: J Bone Miner Res. 2006 Sep;21(9):1339-49
references: 16939392
references: Am J Clin Pathol. 2002 Feb;117(2):210-6
references: 11863217